Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Daily Market Overview Sp 500 Nasdaq Edge Higher Dow Notches Small Dip 20260403 1 Hims Stock Analysis Hims And Hers Health 3.53 Dip Near 19.14 Key Support Level 20260403 Is Quanta Services Pwr Stock A Growth Play Price At 556.37 Down 0.76 20260406 Is Eason Tech Dxf Stock Testing Resistance Price At 0.71 Down 6.41 20260413 What Limits Growth Of Cytosorbents Ctso Stock Price At 0.63 Up 3.44 20260408 LFVN Lifevantage Corporation shares climb 46 percent despite narrow Q1 2026 EPS miss against analyst consensus estimates GOOS Canada posts 15 EPS miss in Q1 but shares hold steady as revenue edges up 1 CAC Camden National Corporation shares rise 31 percent despite narrowly missing Q4 2025 consensus EPS estimates IRIDEX Corporation IRIX Stock Outlook Q4 2025 EPS Tops Views Is Oscar Health OSCR stock holding support levels Oscar Health Posts 37 EPS Miss Amid Cost Pressure Osprey OBTC Stock Is It a Smart Buy OBTC Latest Quarter Earnings Osprey bitcoin trust results track BTC price moves Star STHO Stock Market Confidence Review Karooooo KARO Stock Is It Overpriced Technical Weakness 20260420 Is 3M Company MMM stock overbought in valuation terms Technical Weakness 20260420 OpenAI Founding Dispute Trial First Week Key Takeaways and Sector Implications CMTL Comtech reports narrower Q1 2026 loss than expectations shares tick higher following earnings release KGHM Polska Miedz WSEKGH Shifting Valuation Narratives Amid Divergent Analyst Calls and Operational Milestones UNCY Unicycive Therapeutics reports wide Q4 2025 EPS miss shares dip slightly amid soft investor sentiment How Crescent Cap CCAP adapts when conditions change Drifts Lower 20260508 Inheriting an HSA The Tax Surprise That Could Cost You and How to Avoid It AI Revolution in Banking PwC Highlights Transformative Trends Reshaping the Industry eToro ETOR Stock Slides 133 Support at 3897 20260515 GRI Bio GRI Q1 2026 Results Miss Estimates EPS 161 vs 091 How Crude Oil Price Fluctuations Shape Upstream and Downstream Companies Differently Gladstone GLAD Stock Analysis RangeBound Near 1927 20260518 Mobix Labs MOBXW Down 909 How Low Could It Go 20260518 Boqii BQ Declines 476 Amid Market Weakness 20260515 Northern Trust Preferred Shares NTRSO Edge Lower as Yield Sensitivity Weighs on Sentiment Bilibili BILI Q1 2026 Results A Closer Look at the Earnings Beat Nvidia Earnings Call in Spotlight Geopolitical Tensions and Market Test Loom as Jensen Huang Set to Address Trump China Chip Restrictions After Xi Summit UK Education Reforms Urged to Address Youth Unemployment Pipeline Problem Jim Hensons Creature Shop Opens Doors to Public After Decades of Secrecy Bajaj Auto Shares Rise Ahead of Dividend Record Date Announcement US GDP Grew at 2 Annual Rate in First Quarter Signaling Economic Resilience US Natural Gas Futures Decline as Weekend Weather Revisions Suggest Milder Early February Aluminum Price Surge Amid Iran Conflict Intensifies Cost Pressures for Major US Companies BHB Q1 2026 Earnings EPS Misses Estimates Shares Dip Slightly VEL Q1 2026 Earnings EPS Beats Estimates but Stock Dips 217 Entera Bio ENTX Q1 2026 Earnings Narrowing Losses as Cash Burn Remains in Focus MGTX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips Peoples Bancorp of North Carolina PEBK Posts Modest Gains as Support Holds Above 40 Red Cat Holdings RCAT Surges 565 as Drone Sector Momentum Continues Sarepta Therapeutics SRPT Shows Modest Uptick Amid Key Technical Levels A SPAC III Acquisition Corp Unit ASPCU Rises 378 as Momentum Builds Toward Key Resistance Is Poet Poet Stock Risky Now Price At 6.11 Up 9.11 20260402 Is National Ngg Stock In An Uptrend Price At 87.99 Up 1.32 20260402 Simaw Trading Range Narrows Breakout Expected 20260403 1 What Is The Bear Case For Enterprise Ddc Stock Price At 2.00 Up 19.76 20260402 Ipsc Stock Analysis Century Therapeutics Inc. 3.1 Dip To 2.19 Biotech Performance Review 20260401